Indraprastha Medical Corporation Limited

Healthcare · Healthcare Services

NSE: INDRAMEDCO BSE: 532150

₹348.95

Sept. 30, 2026 · NSE · nse_bhavcopy

Peers in Healthcare Services

The largest companies in the same industry by market cap. This company ranks #23 of 62. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.

Company	Market cap (₹ Cr)	PE (TTM)	ROE	1Y return	Div. yield	Quality	Valuation	Momentum
Apollo Hospitals Enterprise Limited	117,407	74.7	20.1%	9.7%	—	73	0	27
Max Healthcare Institute Limited	90,492	126.0	13.4%	-16.5%	0.22%	77	0	26
Fortis Healthcare Limited	58,132	257.5	10.5%	-22.2%	0.13%	49	26	6
Global Health Limited	36,701	76.2	13.9%	4.6%	0.04%	74	0	30
Narayana Hrudayalaya Ltd.	36,609	64.4	17.8%	3.5%	0.25%	66	0	29
Aster DM Quality Care Limited	36,121	207.5	8.8%	10.5%	0.43%	53	0	26
Dr. Lal Path Labs Ltd.	33,310	38.7	20.1%	-37.3%	0.98%	82	0	88
Krishna Institute of Medical Sciences Limited	31,349	111.2	9.5%	8.5%	—	47	0	29
Indraprastha Medical Corporation Limited (this stock)	3,199	17.0	24.8%	-23.4%	1.15%	87	63	13

Valuation multiples

Current only. Market cap is the whole company's; sales/EBITDA are trailing-twelve-month standalone; debt and cash come from the latest filed standalone balance sheet (March 31, 2026). EBITDA = PBT + interest + depreciation.

Enterprise value

₹3,194 Cr

EV / EBITDA

10.5x

EV / Sales

2.10x

Market cap / Sales

2.10x

Earnings yield

5.88%

Quarterly Financials

Download CSV

Standalone Consolidated

↑ Positive

Quarterly Revenue

Jun 2026 quarterly revenue is Rs 415 Cr, up 11.5% YoY.

↑ Positive

Quarterly Net Profit

Jun 2026 quarterly net profit is Rs 56 Cr, up 8.5% YoY.

Period end	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)	Basic EPS
June 30, 2026	406	75	56	₹6.0900
March 31, 2026	365	55	42	₹4.5500
Dec. 31, 2025	372	56	41	₹4.4700
Sept. 30, 2025	381	66	49	₹5.4000
June 30, 2025	365	68	51	₹5.6100
March 31, 2025	334	55	41	₹4.4700
Dec. 31, 2024	325	45	33	₹3.5800
Sept. 30, 2024	350	57	42	₹4.6300
June 30, 2024	348	60	45	₹4.8800
March 31, 2024	315	42	31	₹3.4000
Dec. 31, 2023	306	41	29	₹3.2100
Sept. 30, 2023	317	44	33	₹3.5800
June 30, 2023	307	40	30	₹3.3300

Quarterly income statement (standalone, ₹ Cr)

Indicator	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23
Total income (before exceptional items)	415	372	379	388	372	340	330	356	353	320	311	321	310
Operating revenue	406	365	372	381	365	334	325	350	348	315	306	317	307
Other income	8	7	7	7	7	6	5	6	5	5	4	4	4
Operating expenses	326	304	310	310	292	272	273	286	281	266	259	267	259
Operating profit	80	61	62	71	73	61	52	64	67	48	47	50	47
Operating profit margin	19.7%	16.6%	16.7%	18.7%	20.0%	18.4%	16.1%	18.2%	19.3%	15.4%	15.4%	15.9%	15.4%
Depreciation	12	11	11	11	10	11	11	11	11	10	10	10	10
Interest	2	1	1	2	2	1	2	2	2	2	1	1	1
Exceptional items, gain / (loss)	—	—	—	—	—	—	—	—	—	—	—	—	—
Profit before tax	75	55	56	66	68	55	45	57	60	42	41	44	40
Tax	19	13	15	17	17	14	12	15	15	10	11	11	10
Net profit	56	42	41	49	51	41	33	42	45	31	29	33	30
EPS	6.09	4.55	4.47	5.40	5.61	4.47	3.58	4.63	4.88	3.40	3.21	3.58	3.33
Net profit (TTM)	188	184	183	175	168	161	151	148	138	124	113	104	96
EPS (TTM)	20.51	20.03	19.95	19.06	18.29	17.56	16.49	16.12	15.07	13.52	12.28	11.35	10.51

Total income excludes exceptional items, which are shown on their own row. Trendlyne and Screener fold exceptional items into revenue or other income, so their totals differ from this table by exactly that row.

Annual Financials

Year ended	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)
March 31, 2026	1,483	246	184
March 31, 2025	1,356	216	161
March 31, 2024	1,245	166	124
March 31, 2023	1,099	117	86

Annual income statement (standalone, ₹ Cr; CAGR to the latest year)

Indicator	CAGR 3Y	CAGR 5Y	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Total income (before exceptional items)	10.9%	19.7%	1,511^†	1,379^†	1,262^†	1,108^†	891^†	614^†	831^†	789^†	749^†	769^†
Operating revenue	10.5%	19.3%	1,483	1,356	1,245	1,099	888^†	613^†	831^†	788^†	748^†	767^†
Other income	—	—	29^†	23^†	17^†	9^†	3^†	1^†	1^†	0^†	1^†	2^†
Operating expenses	—	—	1,216^†	1,112^†	1,051^†	948^†	774^†	573^†	744^†	707^†	676^†	683^†
Operating profit	21.0%	46.0%	267^†	244^†	193^†	151^†	114^†	40^†	86^†	81^†	73^†	84^†
Operating profit margin	—	—	18.0%^†	18.0%^†	15.5%^†	13.7%^†	12.9%^†	6.6%^†	10.4%^†	10.2%^†	9.7%^†	11.0%^†
Depreciation	—	—	44^†	44^†	40^†	39^†	35^†	33^†	33^†	30^†	31^†	31^†
Interest	—	—	6^†	6^†	4^†	4^†	3^†	3^†	6^†	7^†	9^†	8^†
Exceptional items, gain / (loss)	—	—	0^†	0^†	0^†	0^†	0^†	0^†	0^†	0^†	0^†	0^†
Profit before tax	28.0%	124.8%	246	216	166	117	79^†	4^†	48^†	45^†	34^†	42^†
Tax	—	—	62^†	55^†	42^†	31^†	20^†	2^†	5^†	16^†	13^†	15^†
Net profit	28.7%	139.5%	184	161	124	86	59^†	2^†	44^†	28^†	21^†	27^†
EPS	28.7%	138.4%	20.03^†	17.56^†	13.52^†	9.39^†	6.40^†	0.26^†	4.76^†	—	—	—

^† Derived: the sum of that fiscal year's four quarterly filings (a real annual filing is used wherever one exists). Checked against filed annual figures, the sum lands within 0.5% for about 94% of company-years.

Annual ratios (standalone)

Ratio	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Operating margin	18.0%^†	18.0%^†	15.5%^†	13.7%^†	12.9%^†	6.6%^†	10.4%^†	10.2%^†	9.7%^†	11.0%^†
EBIT margin	17.0%^†	16.4%^†	13.7%^†	11.1%^†	9.3%^†	1.2%^†	6.5%^†	6.5%^†	5.7%^†	6.5%^†
PBT margin	16.6%	15.9%	13.3%	10.7%	8.9%^†	0.7%^†	5.8%^†	5.7%^†	4.5%^†	5.5%^†
Net margin	12.4%	11.9%	10.0%	7.8%	6.6%^†	0.4%^†	5.3%^†	3.6%^†	2.8%^†	3.5%^†
Interest coverage	41.87x^†	35.50x^†	41.91x^†	28.38x^†	24.20x^†	2.29x^†	9.14x^†	7.49x^†	4.82x^†	6.30x^†
Dividend payout	22.5%^†	25.6%^†	22.2%^†	26.6%^†	0.0%^†	0.0%^†	33.6%^†	—	—	—
Earnings retention	77.5%^†	74.4%^†	77.8%^†	73.4%^†	100.0%^†	100.0%^†	66.4%^†	—	—	—
Current ratio	2.46x	2.41x	—	—	—	—	—	—	—	—
Quick ratio	2.41x	2.37x	—	—	—	—	—	—	—	—
Debt to equity	0.00x	0.00x	—	—	—	—	—	—	—	—
Return on equity	24.8%	27.0%	—	—	—	—	—	—	—	—
Return on assets	18.5%	18.9%	—	—	—	—	—	—	—	—
Return on capital employed	30.7%^†	33.1%^†	—	—	—	—	—	—	—	—
Asset turnover	1.50x	1.59x	—	—	—	—	—	—	—	—

Margins and asset turnover use operating revenue (interest earned for banks, excluding other income), not total income. Liquidity, leverage and return ratios need a filed standalone balance sheet, which exists only for recent years; returns use year-end equity/assets. Dividend payout is shown only for companies with a dividend record. † = built from a summed fiscal year.

Revenue Mix

Data unavailable.

Cash Flow

Year ended	Operating (₹ Cr)	Investing (₹ Cr)	Financing (₹ Cr)	Capex (₹ Cr)	Free Cash Flow (₹ Cr)
March 31, 2026	167	-178	-46	60	108
March 31, 2025	157	-111	-46	36	120
March 31, 2024	200	-158	-32	69	131
March 31, 2023	144	-108	-26	45	100
March 31, 2022	71	-51	-3	29	42

Balance Sheet (standalone)

Year ended	Total Assets (₹ Cr)	Total Equity (₹ Cr)	Reserves (₹ Cr)	Borrowings, Current (₹ Cr)	Borrowings, Non-current (₹ Cr)	Current Assets (₹ Cr)	Current Liabilities (₹ Cr)	Cash & Equivalents (₹ Cr)	Net Block (₹ Cr)	Inventory (₹ Cr)
March 31, 2026	991	740	649	0	0	417	170	5	364	8
March 31, 2025	852	597	505	0	0	431	179	61	327	7
March 31, 2024	—	—	—	—	—	—	—	—	—	—
March 31, 2023	—	—	—	—	—	—	—	—	—	—
March 31, 2022	—	—	—	—	—	—	—	—	—	—

Financial charts

Trend charts drawn from the standalone income-statement and ratio tables above (oldest year on the left); a gap means that period has no figure. Annual years marked † in the tables are derived from four quarters.